Features and News

ARK Crushed By Concentrated Bet In Teladoc

Shares of the telemedicine provider were cut in half on Thursday, pressuring 'ARKK' and other ETFs.

Features and News

Cathie Wood Snaps Back At Critics, Predicts 50% Annual Returns

The ARK CEO remains steadfast in her belief that her exchange-traded funds will outperform again.

Features and News

ARK Faithful Hold Firm—Mostly

Year-to-date, 'ARKK' still has inflows, but the other ETFs in ARK’s suite have shed assets.

Features and News

Yield Spikes Muddy ARK’s Waters

Cathie Wood’s multibillion-dollar funds are off to a rocky start in 2022.

Features and News

Worst Performing ETFs Of 2021

The worst performers fell by 25% to 72% over the course of 2021.

Daily ETF Watch

ARK Launches ‘Transparency’ ETF

The index-following ETF comes as Cathie Wood’s active funds suffer.

Features and News

ARK Funds Leaking Assets

After a period of underperformance, some ARK investors are jumping ship.

Daily Hot Reads

Hot Reads: US To Release 50M In Oil Reserves

Plus, a big outflow from 'ARKG.'

Features and News


Join us for a triple-header to determine the best genomics biotech ETF!